Pfizer
PFE
PFE
2,254 hedge funds and large institutions have $185B invested in Pfizer in 2018 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 811 increasing their positions, 1,072 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more funds holding
Funds holding: 2,202 → 2,254 (+52)
0.02% more ownership
Funds ownership: 75.67% → 75.7% (+0.02%)
24% less repeat investments, than reductions
Existing positions increased: 811 | Existing positions reduced: 1,072
Holders
2,254
Holding in Top 10
260
Calls
$1.32B
Puts
$1.14B
Top Buyers
| 1 | +$1.92B | |
| 2 | +$548M | |
| 3 | +$353M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$274M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$269M |
Top Sellers
| 1 | -$460M | |
| 2 | -$377M | |
| 3 | -$319M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$218M |
| 5 |
BlackRock
New York
|
-$184M |